These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 6290198)

  • 41. cAMP-dependent ACTH secretagogues facilitate corticotropin releasing activity of angiotensin II on rat anterior pituitary cells in vitro.
    Schoenenberg P; Gaillard RC; Kehrer P; Muller AF
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):118-23. PubMed ID: 3028024
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of the reverse hemolytic plaque assay to study the regulation of anterior lobe adrenocorticotropin (ACTH) secretion by ACTH-releasing factor, arginine vasopressin, angiotensin II, and glucocorticoids.
    Childs GV; Burke JA
    Endocrinology; 1987 Feb; 120(2):439-44. PubMed ID: 3026776
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of CRF, AVP and NE on cAMP in cultured rat anterior pituitary cells during hypoxia].
    Chen Z; Du J
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 1997 Nov; 13(4):295-8. PubMed ID: 10322950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transmembrane signals mediating adrenocorticotropin release from mouse anterior pituitary cells.
    Castro MG; Gusovsky F; Loh YP
    Mol Cell Endocrinol; 1989 Aug; 65(1-2):165-73. PubMed ID: 2550296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucocorticoids act rapidly in vitro to attenuate second messenger responses to ACTH secretagogues in rats.
    Nicholson SA; Gillham B
    J Endocrinol; 1989 Aug; 122(2):545-51. PubMed ID: 2549163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release.
    Samson WK; Murphy T; Schell DA
    Endocrinology; 1995 May; 136(5):2349-52. PubMed ID: 7720684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ACTH-releasing activity of urotensin I and ovine CRF: interactions with arginine vasotocin, isotocin and arginine vasopressin.
    Fryer J; Lederis K; Rivier J
    Regul Pept; 1985 May; 11(1):11-5. PubMed ID: 2989979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of several in vitro systems on the potencies of putative adrenocorticotropin secretagogues on rat anterior pituitary cells.
    Watanabe T; Orth DN
    Endocrinology; 1988 May; 122(5):2299-308. PubMed ID: 2834188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of corticotrophin-releasing hormone, arginine vasopressin and their antagonists on ACTH release from perifused horse anterior pituitary cells.
    Ellis MJ; Mulligan RS; Evans MJ; Donald RA
    J Endocrinol; 1994 Oct; 143(1):85-93. PubMed ID: 7964325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC
    Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinct receptor subtypes mediate arginine vasopressin-dependent ACTH release and intracellular calcium mobilization in rat pituitary cells.
    Perdonà E; Arban R; Griffante C
    Eur J Pharmacol; 2012 Mar; 679(1-3):16-23. PubMed ID: 22285855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel type of vasopressin receptor on anterior pituitary corticotrophs?
    Baertschi AJ; Friedli M
    Endocrinology; 1985 Feb; 116(2):499-502. PubMed ID: 2981663
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of synthetic ovine corticotropin-releasing factor (CRF) on ACTH release in vitro].
    Murakami K; Hashimoto K; Kageyama Z; Takahara J; Ota Z
    Nihon Naibunpi Gakkai Zasshi; 1983 Jul; 59(7):983-92. PubMed ID: 6313440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delta-sleep-inducing peptide (DSIP) inhibited CRF-induced ACTH secretion from rat anterior pituitary gland in vitro.
    Okajima T; Hertting G
    Horm Metab Res; 1986 Jul; 18(7):497-9. PubMed ID: 3017833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple factors controlling ACTH secretion at the anterior pituitary level.
    Labrie F; Giguère V; Meunier H; Simard J; Gossard F; Raymond V
    Ann N Y Acad Sci; 1987; 512():97-114. PubMed ID: 2894795
    [No Abstract]   [Full Text] [Related]  

  • 56. Inactivation of early glucocorticoid feedback by corticotropin-releasing factor in vitro.
    Shipston MJ; Antoni FA
    Endocrinology; 1992 Apr; 130(4):2213-8. PubMed ID: 1312450
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro potentiation of the activity of synthetic ovine corticotropin-releasing factor by arginine vasopressin.
    Turkelson CM; Thomas CR; Arimura A; Chang D; Chang JK; Shimizu M
    Peptides; 1982; 3(2):111-3. PubMed ID: 6285317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth hormone-releasing factor releases ACTH from an AtT-20 mouse pituitary tumor cell line but not from normal pituitary cells.
    Nakane T; Tsai J; Audhya T; Brown C; Kardos P; Hollander CS
    Life Sci; 1987 Jun; 40(22):2161-7. PubMed ID: 2884543
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of urocortin and its interaction with adrenocorticotropin (ACTH) secretagogues on ACTH release.
    Ozawa M; Oki Y; Watanabe F; Iino K; Masuzawa M; Iwabuchi M; Yoshimi T
    Peptides; 1998; 19(3):513-8. PubMed ID: 9533639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action.
    Giguère V; Labrie F; Côté J; Coy DH; Sueiras-Diaz J; Schally AV
    Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3466-9. PubMed ID: 6285350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.